Polymorphisms of IL-6 174 G/C, IL-10 -592 C/A and risk of HIV/AIDS among North Indian population

Molecular and Cellular Biochemistry

Volumn 337, Issue 1-2, 2010, Pages 145-152

  Sobti, Ranbir Chander ^a   Berhane, Nega ^a   Mahedi, Salih Abdul ^a   Kler, Rupinder ^a   Hosseini, Seyed Ali ^a   Kuttiat, Vijish ^b   Wanchu, Ajay ^b  

^a PANJAB UNIVERSITY   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Disease progression; HIV AIDS; IL 10; IL 6; PCR; RFLP

Indexed keywords

ADENINE; CYTOSINE; GUANINE; INTERLEUKIN 10; INTERLEUKIN 6;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HEREDITY; HOMOZYGOSITY; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIAN; INFECTION RISK; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VIRUS REPLICATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; CASE-CONTROL STUDIES; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HIV-1; HUMANS; INDIA; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 77949655922     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-009-0293-0     Document Type: Article

References (50)

1. AIDS epidemic update (2008). http://www.unaids.org. Accessed on 12 Jan 2009
2. S Godbole S Mehendale 2005 HIV/AIDS epidemic in India: risk factors. Risk behaviour & strategies for prevention & control Indian J Med Res 121 356 368 15817949
3. NL Michael 2002 Host genetics and HIV-removing the mask Nat Med 8 783 785 10.1038/nm0802-783 1:CAS:528:DC%2BD38Xls12ms7k%3D 12152029
4. JW Ward TJ Bush HA Perkins LE Lieb JR Allen D Goldfinger SM Samson SH Pepkowitz LP Fernando PV Holland SH Kleinman AJ Grindon PA Graner GW Rutherford SD Holmberg 1989 The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease N Engl J Med 321 947 952 1:STN:280:DyaL1MzosVyjsw%3D%3D 2779617
5. KR Fowke ND Nagelkerke J Kimani JN Simonsen AO Anzala JJ Bwayo KS McDonald EN Ngugi FA Plummer 1996 Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Plummer Lancet 348 1347 1351 10.1016/S0140-6736(95)12269-2 1:STN:280:DyaK2s%2FnsF2mtw%3D%3D 8918278 (Pubitemid 26383775)
6. SL Rowland-Jones A McMichael 1995 Immune responses in HIV-exposed seronegatives: have they repelled the virus? Curr Opin Immunol 7 448 455 10.1016/0952-7915(95)80087-5 1:CAS:528:DyaK2MXotF2ksrg%3D 7495507
7. GM Shearer M Clerici 1996 Protective immunity against HIV infection: has nature done the experiment for us? Immunol Today 17 21 24 10.1016/0167-5699(96) 80564-0 1:CAS:528:DyaK28XlsF2ntg%3D%3D 8652046 (Pubitemid 26019253)
8. J Heeney P Beverley A McMichael G Shearer J Strominger B Wahren J Weber F Gotch 1999 Immune correlates of protection from HIV and AIDS-more answers but yet more questions Immunol Today 20 247 251 10.1016/S0167-5699(98)01437-6 1:CAS:528:DyaK1MXjvVGrsLw%3D 10354547 (Pubitemid 29258159)
9. PS Kulkarni ST Butera AC Duerr 2003 Resistance to HIV-1 infection: lessons learned from studies of highly exposed persistently seronegative (HEPS) individuals AIDS Rev 5 87 103 12876898
10. MA Nowak RM Anderson AR McLeann TF Wolfs J Goudsmit RM May 1991 Antigenic diversity thresholds and the development of AIDS Science 254 963 969 10.1126/science.1683006 1:STN:280:DyaK38%2FlsVKjtw%3D%3D 1683006
11. RJ Biggar 1990 AIDS incubation in 1981 HIV seroconverters from different exposure groups AIDS 4 1059 1065 10.1097/00002030-199011000-00002 1:STN:280:DyaK3M7ivVKmtA%3D%3D 2282177
12. T Kishimoto S Akira T Taga 1992 Interleukin-6 and its receptor: a paradigm for cytokines Science 258 593 597 10.1126/science.1411569 1:CAS:528:DyaK38XmsV2lsbg%3D 1411569
13. J Pasic WC Levy MD Sullivan 2003 Cytokines in depression and heart failure Psychosom Med 65 181 193 10.1097/01.PSY.0000058372.50240.38 12651985 (Pubitemid 36359329)
14. G Ramadori B Christ 1999 Cytokines and the hepatic acute-phase response Semin Liver Dis 19 141 155 10.1055/s-2007-1007106 1:CAS:528:DyaK1MXkvFeisrk%3D 10422197
15. D Fishman G Faulds R Jeffery V Mohamed-Ali JS Yudkin S Humphries P Woo 1998 The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis J Clin Invest 102 1369 1376 10.1172/JCI2629 1:CAS:528:DyaK1cXmsFOrsrY%3D 9769329
16. JM McNicholl DK Smith SH Qari T Hodge 1997 Host genes and HIV: the role of the chemokine receptor gene CCR5 and its allele Emerg Infect Dis 3 3261 3271 10.3201/eid0303.970302
17. SJ O'Brien M Dean 1997 In search of AIDS-resistance genes Sci Am 277 44 51 10.1038/scientificamerican0997-44 9274039
18. S Mocellin FM Marincola HA Young 2005 Interleukin-10 and the immune response against cancer: a counterpoint J Leukoc Biol 78 1043 1105 10.1189/jlb.0705358 1:CAS:528:DC%2BD2MXht1ShsL%2FN 16204623 (Pubitemid 41572467)
19. G Del Prete M De Carli F Almerigogna MG Giudizi R Biagiotti S Romagnani 1993 Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production J Immunol 150 353 360 8419468
20. RG Westendorp JA Langermans TW Huizinga CL Verweij A Sturk 1997 Genetic influence on cytokine production in meningococcal disease Lancet 349 1912 1913 10.1016/S0140-6736(05)63910-4 1:STN:280:DyaK2szmtVyitQ%3D%3D 9217780 (Pubitemid 27270137)
21. J Eskdale V Keijsers T Huizinga G Gallagher 1999 Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus Genes Immun 1 151 155 10.1038/sj.gene.6363656 1:CAS:528:DC%2BD3cXktlyhu70%3D 11196662
22. U Langsenlehner P Krippl W Renner B Yazdani-Biuki T Eder H Köppel TC Wascher B Paulweber H Samonigg 2005 Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk Breast Cancer Res Treat 90 113 115 10.1007/s10549-004-3607-7 1:CAS:528:DC%2BD2MXivVKhs74%3D 15803357 (Pubitemid 40568894)
23. A De Michele AM Martin R Mick P Gor L Wray M Klein-Cabral G Athanasiadis T Colligan E Stadtmauer B Weber 2003 Interleukin-6-174G→C polymorphism is associated with improved outcome in high-risk breast cancer Cancer Res 63 8051 8056
24. SE Humphries LA Luong MS Ogg E Hawe GJ Miller 2001 The interleukin-6-174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men Eur Heart J 22 2243 2252 10.1053/euhj.2001.2678 1:CAS:528:DC%2BD38XltVansQ%3D%3D 11728144 (Pubitemid 34000979)
25. J Cavet AM Dickinson J Norden PR Taylor GH Jackson PG Middleton 2001 Interferon-γ and interleukin-6 gene polymorphisms associate with graft-versus host disease in HLA-matched sibling bone marrow transplantation Blood 98 1594 1600 10.1182/blood.V98.5.1594 1:CAS:528:DC%2BD3MXmvFGjtbY%3D 11520812
26. J Hulkkonen M Pertovaara J Antonen A Pasternack M Hurme 2001 Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjogren's syndrome and correlate with the clinical manifestations of the disease Rheumatology 40 656 661 10.1093/rheumatology/40.6. 656 1:CAS:528:DC%2BD3MXlsFSiu7o%3D 11426023
27. R Pecoits-Filho B Lindholm J Axelsson P Stenvinkel 2003 Update on interleukin-6 and its role in chronic renal failure Nephrol Dial Transplant 18 1042 1045 10.1093/ndt/gfg111 1:CAS:528:DC%2BD3sXjvFCmtrY%3D 12748331 (Pubitemid 36722500)
28. RM Bologa DM Levine TS Parker JS Cheigh D Serur KH Stenzel AL Rubin 1998 Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients Am J Kidney Dis 32 107 114 10.1053/ajkd.1998.v32.pm9669431 1:STN:280:DyaK1czjt1Sqtg%3D%3D 9669431
29. ED Cox SC Hoffmann BS DiMercurio RA Wesley DM Harlan AD Kirk PJ Blair 2001 Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6 Transplantation 72 720 772 10.1097/00007890-200108270-00027 1:CAS:528:DC%2BD3MXntFKhsL4%3D 11544437
30. CF Terry V Loukaci FR Green 2000 Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation J Biol Chem 275 18138 18144 10.1074/jbc.M000379200 1:CAS:528:DC%2BD3cXktlymtLw%3D 10747905 (Pubitemid 30414764)
31. MA Vickers FR Green C Terry BM Mayosi C Julier M Lathrop PJ Ratcliffe HC Watkins B Keavney 2002 Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein Cardiovasc Res 53 1029 1034 10.1016/S0008-6363(01)00534-X 1:CAS:528:DC%2BD38Xitlaqu70%3D 11922913 (Pubitemid 34261041)
32. M Matsuda F Salazar M Petersson G Masucci J Hansson P Pisa QJ Zhang MG Masucci R Kiessling 1994 Interleukin 10 pretreatment protects target cells from tumor- and allospecific cytotoxic T cells and downregulates HLA class I expression J Exp Med 120 2371 2376 10.1084/jem.180.6.2371 (Pubitemid 24351621)
33. C Fortis M Foppoli L Gianotti L Galli G Citterio G Consogno O Gentilini M Bragaet 1996 Increased interleukin-10 serum levels in patients with solid tumours Cancer Lett 104 1 5 10.1016/0304-3835(96)04213-9 1:CAS:528: DyaK28Xjt1Sgtrw%3D 8640735 (Pubitemid 26154004)
34. X Zhang P Hei L Deng J Lin 2007 Interleukin-10 gene promoter polymorphisms and their protein production in peritoneal fluid in patients with endometriosis Mole Hum Reprod 13 135 140 10.1093/molehr/gal106 1:CAS:528:DC%2BD2sXotFCrsg%3D%3D (Pubitemid 46152600)
35. DM Turner DM Williams D Sankaran M Lazarus PJ Sinnott IV Hutchinson 1998 An investigation of polymorphism in the interleukin-10 gene promoter Eur J Immunogenet 24 1 8
36. T van der Poll A Marchant CV Koeogh M Goldman SF Lowry 1996 Interleukin-10 impairs host defense in murine pneumococcal pneumonia J Infect Dis 174 994 1000 8896500
37. MJ Greenberger RM Strieter SL Kunkel JM Danforth RE Goodman TJ Standiford 1995 Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia J Immunol 155 722 729 1:CAS:528:DyaK2MXmvVagsL8%3D 7608550
38. R Kühn J Lohler D Rennick K Rajewsky W Muller 1993 Interleukin-10-deficient mice develop chronic enterocolitis Cell 75 263 274 10.1016/0092-8674(93)80068-P
39. SM Opal VA De Pa 2000 Anti-inflammatory cytokines Chest 117 1162 1172 10.1378/chest.117.4.1162 1:CAS:528:DC%2BD3cXjtFahsb0%3D 10767254
40. RJ Baier J Loggins K Yanamandra 2006 IL-10, IL-6 and CD14 polymorphisms and sepsis outcome in ventilated very low birth weight infants BMC Med 4 1 11 10.1186/1741-7015-4-10 (Pubitemid 44136948)
41. R De Waal Malefyt J Abrams B Bennett CG Figdor JE De Vries 1991 Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes J Exp Med 174 1209 1220 10.1084/jem.174.5.1209 1940799
42. PJ Murray L Wang C Onufryk RI Tepper RA Young 1997 T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection J Immunol 158 15 21
43. L Llorente Y Richaud-Patin R Fior J Alcocer-Varela J Wijdenes BM Fourrier P Galanaud D Emilie 1994 In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjogren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity Arthr Rheum 37 1647 1655 10.1002/art.1780371114 1:STN:280:DyaK2M%2FntFGnsQ%3D%3D (Pubitemid 24345813)
44. D Mason F Powrie 1998 Control of immune pathology by regulatory T cells Curr Opin Immunol 10 649 655 10.1016/S0952-7915(98)80084-8 1:CAS:528: DyaK1MXhtlGg 9914214 (Pubitemid 28558579)
45. J Kim RL Modlin RL Moy SM Dubinett T McHugh BJ Nickoloff K Uyemura 1995 IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response J Immunol 155 2240 1:CAS:528:DyaK2MXnsVShsLo%3D 7636270
46. LC Miller EA Lynch S Isa JW Logan CA Dinarello AC Steere 1993 Balance of synovial fluid IL-1 beta and IL-1 receptor antagonist and recovery from lyme arthritis Lancet 341 146 148 10.1016/0140-6736(93)90006-3 1:STN:280: DyaK3s7ktVCgug%3D%3D 8093746 (Pubitemid 23029308)
47. E Girardin P Roux-Lombard GE Grau P Suter H Gallati 1992 Imbalance between tumor necrosis factor alpha and soluble TNF receptor levels in severe meningococcemia Immunology 76 20 23 1:CAS:528:DyaK38XksVKgtr0%3D 1321092
48. J Villard P Roux-Lombard A Hugli JM Dayer 1993 Could natural inhibitors of tumor necrosis factor alpha modify the clinical course of fulminant meningococcemia? Critical Care Med 21 1396 1400 1:STN:280:DyaK3szotVelsw%3D%3D
49. GT Spear A MEAF MH Cohen J Bremer AL Landay 2005 Relationship of HIV RNA and cytokines in saliva from HIV-infected individuals FEMS Immunol Med Microbiol 45 129 136 10.1016/j.femsim.2005.03.002 1:CAS:528:DC%2BD2MXmvVKgsbk%3D 16051064 (Pubitemid 41039996)
50. TJ Scriba HT Zhang HL Brown A Oxenius N Tamm S Fidler J Fox JN Weber P Klenerman CL Day M Lucas RE Phillips 2005 HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound J Clin Invest 115 443 450 1:CAS:528:DC%2BD2MXhtFyjtr4%3D 15668739